Compound ID | 241
Synonym(s): TP-6076
Class: Tetracycline
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor. Binds to 30S ribosomal subunit |
| Target Pathogen: | Active against carbapenem-resistant Enterobacteriaceae including multidrug-resistant Acinetobacter |
| Propensity to select resistant mutants: | Yes |
| Description: | Contains fluorocycline scaffold; In Vivo Efficacy of Novel, Fully Synthetic Tetracyclines in a Murine Lung Infection Model Challenged with KPC-producing Klebsiella pneumoniae;T. Grossman, C. Fyfe, K. Kerstein, C. Sun, D. Hunt, R. Clark, X. Xiao, J. Sutcliffe |
| Institute where first reported: | Tetraphase Pharmaceuticals, USA |
| Year first mentioned: | 2014 |
| Highest development stage: | Phase 1 (NCT03691584) |
| Development status: | Active |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/162423126 |
| Guide to Pharmacology: | TP-6076 |
| Citations: |
|